ReviewInternational journal of biological macromolecules2026
The curious life of human mitochondrial SOD2.
Review in International journal of biological macromolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Extracellular Redox Balance as a Determinant of Immune Regulation and Tissue Inflammation.Antioxidants (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Human manganese superoxide dismutase (MnSOD2) is a critical mitochondrial antioxidant that catalyzes the conversion of highly reactive superoxide radicals into molecular oxygen and hydrogen peroxide. The peroxide molecules are subsequently neutralized by other antioxidant systems, positioning MnSOD2 as the primary defense against mitochondrial oxidative stress and diseases associated with disrupted in vivo redox balance. MnSOD2 has been studied since its discovery in the early 1960s, particularly in the context of cellular pathology and as a therapeutic target. Recent studies combining neutron protein crystallography (NPC), X-ray absorption spectroscopy (XAS), and quantum mechanical (QM) computations have uncovered previously uncharacterized protonation states and atypically short and strong hydrogen bonds within the active site of MnSOD2. Together, these drive the enzyme's exceptionally rapid turnover. This focused review summarizes emerging insights to generate an updated landscape of MnSOD2's structure-function relationship and to highlight remaining challenges. The primary bottleneck to a complete understanding of the structural mechanism of MnSOD2 catalysis is the lack of a superoxide-bound MnSOD2 structure that resolves all proton positions, defines the redox state of the catalytic metal, the metal ligands, and the position of superoxide. Additionally, another largely unexplored area is how Fe substitution converts MnSOD2 into a peroxidase, and how this metal promiscuity affects mitochondrial redox homeostasis. This review synthesizes current evidence and states an informed hypothesis for the catalytic mechanism of Fe-substituted SOD2 (FeSOD2). Clarifying these gaps will advance our understanding of the structural basis of SOD2 catalysis and how it shapes mitochondrial redox biology in health and disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.